STOCK TITAN

Airsculpt Technologies, Inc. - AIRS STOCK NEWS

Welcome to our dedicated page for Airsculpt Technologies news (Ticker: AIRS), a resource for investors and traders seeking the latest updates and insights on Airsculpt Technologies stock.

About AirSculpt Technologies, Inc.

AirSculpt Technologies, Inc. (NASDAQ: AIRS) is a leading provider of premium body contouring procedures, operating under its exclusive brand, Elite Body Sculpture. The company specializes in delivering minimally invasive fat removal and body sculpting treatments using its patented AirSculpt® technology. Designed to optimize precision and patient comfort, the AirSculpt® procedure offers a modern alternative to traditional liposuction by combining fat removal and skin tightening in a single treatment. This innovative approach allows for faster healing, minimal bruising, and natural-looking results, catering to patients seeking advanced aesthetic solutions.

Business Model and Operations

AirSculpt operates a direct-to-consumer business model, with revenue generated through elective medical procedures performed at its dedicated clinics. The company employs an asset-light business strategy, focusing on operating premium centers equipped with state-of-the-art technology. Each location is designed to enhance the patient experience, providing a luxurious and comfortable environment. Currently, AirSculpt has expanded its presence to over 30 locations across the United States, Canada, and the United Kingdom, with plans for continued growth in response to increasing consumer demand for its services.

Proprietary Technology and Differentiation

At the core of AirSculpt's value proposition is its proprietary AirSculpt® technology, a minimally invasive fat removal method that uses a patented technique to remove unwanted fat while simultaneously tightening the skin. Unlike traditional liposuction, AirSculpt requires no general anesthesia, reduces trauma to surrounding tissues, and enables quicker recovery times. The company has also developed complementary procedures, such as AirSculpt®+ skin tightening and AirSculpt® Lift, which further enhance its offerings by addressing skin laxity and facial rejuvenation.

Market Position and Industry Context

AirSculpt Technologies operates within the growing aesthetics and body contouring market, a sector driven by rising consumer interest in minimally invasive cosmetic procedures. The company's unique technology and premium branding position it as a key player in this space, competing with both surgical and non-surgical alternatives. Its focus on delivering consistent, high-quality results has contributed to a strong reputation among patients, with more than 70,000 procedures successfully performed since its inception in 2012.

Challenges and Competitive Landscape

While AirSculpt benefits from a differentiated product offering and growing market demand, it faces competition from traditional liposuction providers and emerging non-invasive technologies such as CoolSculpting and laser-based fat reduction methods. Additionally, the elective nature of its procedures makes it sensitive to economic fluctuations. To mitigate these challenges, the company emphasizes innovation, operational efficiency, and strategic location expansion to capture a larger share of the addressable market.

Future Outlook

AirSculpt Technologies is well-positioned to capitalize on the increasing demand for aesthetic procedures. With a focus on expanding its clinic network, enhancing operational efficiencies, and leveraging its proprietary technology, the company aims to drive long-term growth and profitability. Its commitment to delivering exceptional patient outcomes and maintaining a strong brand presence underscores its potential for continued success in the competitive body contouring market.

Rhea-AI Summary

AirSculpt Technologies, Inc. (NASDAQ: AIRS), a national provider of premium body contouring procedures, has announced its plans to report second quarter 2024 financial results. The company will release its earnings before the market opens on Friday, August 9, 2024, followed by a conference call at 8:30 a.m. Eastern Time on the same day.

Investors and interested parties can access the conference call by dialing 1-877-407-9716 (toll-free domestic) or 1-201-493-6779 (international) using the conference ID 13747871. Alternatively, they can request a return call for instant telephone access. A live webcast of the call will be available on the investor relations section of the AirSculpt Technologies website, with a replay accessible for approximately 90 days after the event.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.08%
Tags
conferences earnings
-
Rhea-AI Summary

AirSculpt Technologies, Inc. (NASDAQ:AIRS) reported a 2.9% increase in first-quarter cases to 3,746 and a 3.9% revenue increase to $47.6 million. Net income rose to $6.0 million from a loss in the previous year. The company plans six new center openings in 2024 and maintains revenue guidance of $220 million.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-12.06%
Tags
-
Rhea-AI Summary

AirSculpt Technologies, Inc. announced its plans to release the first quarter 2024 financial results on May 10, 2024, followed by a conference call. The company specializes in premium body contouring procedures and invites investors to join the call for more information.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.25%
Tags
Rhea-AI Summary

AirSculpt® Technologies, Inc., announced the relocation of its Atlanta office and the addition of the AirSculpt®+ skin tightening procedure to its offerings. The new office is in the prime Lenox Overlook area, and AirSculpt+ combines fat removal with skin tightening for enhanced results. The company has performed over 60,000 AirSculpt® cases since 2012 across premium locations in the U.S., Canada, and the U.K.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.53%
Tags
none
-
Rhea-AI Summary
AirSculpt Technologies, Inc. partners with Kristen Doute to showcase her body contouring journey using AirSculpt®, a minimally invasive procedure that removes fat and tightens skin without needles or scalpels. Kristen's experience highlights the effectiveness of the treatment and its positive impact on confidence and body image.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.24%
Tags
none
-
Rhea-AI Summary
AirSculpt Technologies, Inc. (NASDAQ:AIRS) will participate in the BofA Consumer and Retail Conference in Miami Beach on March 13, 2024, showcasing their premium body contouring procedures.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.98%
Tags
none
Rhea-AI Summary
AirSculpt® Technologies, Inc. announces the expansion and redesign of its Scottsdale location, introducing a new procedure, AirSculpt® Lift, while offering a limited time promotion. The company aims to meet the demand for premium body contouring services and enhance patient care with innovative offerings.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.1%
Tags
none
-
Rhea-AI Summary
AirSculpt Technologies, Inc. (NASDAQ:AIRS) reported strong financial results for the fourth quarter and full year ended December 31, 2023, with revenue increasing by 17.0% to $47.6 million in Q4 and 16.1% to $195.9 million for the full year. The company also saw improvements in net loss, adjusted EBITDA, and diluted loss per share compared to the prior year. AirSculpt ended the year with 27 facilities, showing growth in revenue per case. CEO Todd Magazine highlighted the company's growth and expansion strategies, emphasizing brand recognition, store openings, and profit margin expansion.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.06%
Tags
none
-
Rhea-AI Summary
AirSculpt Technologies, Inc. announced it will report fourth quarter 2023 financial results on February 27, 2024. The company will host a conference call at 8:30 a.m. Eastern Time on the same day. The live webcast can be accessed via the investor relations section of the AirSculpt Technologies website. A replay of the webcast will be available for approximately 90 days.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.85%
Tags
Rhea-AI Summary
AirSculpt Technologies, Inc. (NASDAQ:AIRS) announced a 20.3% revenue increase to $46.8 million and a net loss of $(1.7) million for the third quarter of 2023. The company also reported a 19.0% increase in case volume and plans to open at least six new centers in 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.71%
Tags

FAQ

What is the current stock price of Airsculpt Technologies (AIRS)?

The current stock price of Airsculpt Technologies (AIRS) is $4.535 as of February 28, 2025.

What is the market cap of Airsculpt Technologies (AIRS)?

The market cap of Airsculpt Technologies (AIRS) is approximately 258.7M.

What is AirSculpt Technologies, Inc.?

AirSculpt Technologies, Inc. specializes in minimally invasive body contouring procedures using its proprietary AirSculpt® technology.

How does AirSculpt® technology differ from traditional liposuction?

AirSculpt® is a minimally invasive procedure that removes fat and tightens skin without general anesthesia, offering faster recovery and less bruising compared to traditional liposuction.

How does AirSculpt Technologies generate revenue?

The company generates revenue through direct payments for its elective body contouring procedures performed at its dedicated clinics.

What is the competitive advantage of AirSculpt Technologies?

AirSculpt's proprietary technology, premium branding, and focus on patient comfort and precision differentiate it from competitors in the body contouring market.

What are the main challenges AirSculpt Technologies faces?

Key challenges include competition from other aesthetic procedure providers, regulatory compliance, and economic sensitivity due to the elective nature of its services.

Where are AirSculpt clinics located?

AirSculpt operates over 30 clinics across the U.S., Canada, and the United Kingdom, with plans for continued expansion.

What additional procedures does AirSculpt offer?

In addition to fat removal, AirSculpt offers complementary procedures like AirSculpt®+ skin tightening and AirSculpt® Lift for facial rejuvenation.

Who are AirSculpt Technologies' competitors?

Competitors include traditional liposuction providers, non-invasive technologies like CoolSculpting, and other aesthetic procedure providers.

What is the company's growth strategy?

AirSculpt focuses on expanding its clinic network, enhancing operational efficiencies, and leveraging its proprietary technology to capture market demand.

What is the market outlook for body contouring procedures?

The body contouring market is growing due to increasing consumer interest in minimally invasive aesthetic treatments and advancements in technology.
Airsculpt Technologies, Inc.

Nasdaq:AIRS

AIRS Rankings

AIRS Stock Data

258.73M
12.92M
26.91%
73.11%
5.1%
Medical Care Facilities
Services-offices & Clinics of Doctors of Medicine
Link
United States
MIAMI BEACH